ZNF93 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.209600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.679830E-02
Normal-vs-Stage2
3.167800E-02
Normal-vs-Stage3
3.026000E-02
Normal-vs-Stage4
1.212630E-01
Stage1-vs-Stage2
2.551200E-01
Stage1-vs-Stage3
7.702600E-01
Stage1-vs-Stage4
8.332500E-02
Stage2-vs-Stage3
5.166800E-01
Stage2-vs-Stage4
4.160800E-01
Stage3-vs-Stage4
1.146160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.317700E-02
Normal-vs-AfricanAmerican
7.607600E-02
Normal-vs-Asian
4.529500E-02
Caucasian-vs-AfricanAmerican
7.352200E-01
Caucasian-vs-Asian
6.021600E-01
AfricanAmerican-vs-Asian
9.677800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.154190E-02
Normal-vs-Female
4.841800E-02
Male-vs-Female
5.744600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.656300E-02
Normal-vs-Age(41-60Yrs)
7.258200E-02
Normal-vs-Age(61-80Yrs)
1.619820E-02
Normal-vs-Age(81-100Yrs)
6.660500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.606600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.254000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.790600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.192000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.580030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.700400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.219600E-03
Normal-vs-Daily Drinker
4.35870000000671E-05
Normal-vs-Weekly Drinker
2.812800E-01
Normal-vs-Occasional Drinker
2.351500E-02
Normal-vs-Social Drinker
4.064000E-02
Non Drinker-vs-Daily Drinker
8.307500E-02
Non Drinker-vs-Weekly Drinker
5.133000E-01
Non Drinker-vs-Occasional Drinker
5.875800E-01
Non Drinker-vs-Social Drinker
2.550800E-01
Daily Drinker-vs-Weekly Drinker
1.570010E-01
Daily Drinker-vs-Occasional Drinker
2.856500E-02
Daily Drinker-vs-Social Drinker
4.684000E-03
Weekly Drinker-vs-Occasional Drinker
7.231000E-01
Weekly Drinker-vs-Social Drinker
9.878200E-01
Occasional Drinker-vs-Social Drinker
5.675000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.392000E-01
Normal-vs-Grade 2
6.677200E-01
Normal-vs-Grade 3
6.625200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.021200E-01
Grade 1-vs-Grade 3
3.413600E-01
Grade 1-vs-Grade 4
6.392000E-01
Grade 2-vs-Grade 3
8.039400E-01
Grade 2-vs-Grade 4
6.677200E-01
Grade 3-vs-Grade 4
6.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.942500E-03
Normal-vs-NonDiabetic
2.337900E-02
Diabetic-vs-NonDiabetic
7.750000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.455100E-03
Normal-vs-NoPancreatitis
1.001640E-02
Pancreatitis-vs-NoPancreatitis
1.801210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.355400E-03
Normal-vs-N1
4.360100E-02
N0-vs-N1
1.617040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.292800E-01
Normal-vs-TP53-NonMutant
9.318900E-03
TP53-Mutant-vs-TP53-NonMutant
9.132000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
